The Prediction Markets

Market comparison

Will the FDA approve gedatolisib for advanced breast cancer?

1 venue · 5 outcome rows · 0 comparable lines · 0 verified parity · inactive

Kalshi

Open venue ↗

5 outcomes · $7K reported volume

Observed 3020h ago · stale

Recorded venue end date: Jul 1, 2027

Check settlement rules before comparing contracts. Matched outcomes may settle differently. These are stored prices; record update times do not certify live quotes. Differences exclude fees and available size.

No shared outcome identities or comparable outcome lines are available for this event. Each venue’s outcomes are listed separately.

Before Aug 1, 2026

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

63.0%stale

Bid and ask hidden: prices are over 2 hours old

Before Aug 1, 2026 · closed

Open Kalshi ↗

Before Jan 1, 2027

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

76.0%stale

Bid and ask hidden: prices are over 2 hours old

Before Jan 1, 2027 · closed

Open Kalshi ↗

Before Jul 1, 2026

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

15.0%stale

Bid and ask hidden: prices are over 2 hours old

Before Jul 1, 2026 · closed

Open Kalshi ↗

Before Jul 1, 2027

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

77.0%stale

Bid and ask hidden: prices are over 2 hours old

Before Jul 1, 2027 · closed

Open Kalshi ↗

Before Oct 1, 2026

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

71.0%stale

Bid and ask hidden: prices are over 2 hours old

Before Oct 1, 2026 · closed

Open Kalshi ↗

Prices are shown as percentages of a $1 payout. “pp” means percentage points. A dash means data is unavailable.

View event details, charts and rules →Explore more markets